ESC 365 - Inotersen improved quality of life, polyneuropathy and cardiomyopathy in a diverse group of patients with hereditary transthyretin amyloidosis in the phase 3 study NEURO-TTR

ESC Premium Access

Inotersen improved quality of life, polyneuropathy and cardiomyopathy in a diverse group of patients with hereditary transthyretin amyloidosis in the phase 3 study NEURO-TTR

Session: Poster Session 1 - Cardiomyopathies: various aspects

Topic: Infiltrative Myocardial Disease

Speaker: Doctor S. Hughes (Carlsbad, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Steve Hughes

Ionis Pharmaceuticals Inc, Carlsbad (United States of America)

0 follower

9 more presentations in this session

In silico finite element modeling of longitudinal wave propagation for assessment of myocardial stiffness: comparison with findings from patients with cardiac amyloidosis

Speaker: Doctor O. Anupraiwan (Nonthaburi, TH)

Pathology of conduction tissue in cardiac amyloid: correlation with arrhythmic manifestations

Speaker: Associate Professor A. Frustaci (Rome, IT)

Intramyocardial inflammation correlates with poor prognosis in patients with cardiac AL amyloidosis

Speaker: Doctor F. Escher (Berlin, DE)

Hereditary transthyretin amyloidosis is associated with significant disease burden: analysis of the baseline characteristics of patients from the phase 3 study NEURO-TTR

Speaker: Professor T. Damy (Creteil, FR)

Amplitude of inverted T-waves in arrhythmogenic cardiomyopathy in specific right ventricular leads.

Speaker: Associate Professor S. Peters (Norden, DE)

Access the full session

Poster Session 1 - Cardiomyopathies: various aspects

Speakers: Doctor S. Hughes, Doctor O. Anupraiwan, Associate Professor A. Frustaci, Doctor F. Escher, Professor T. Damy...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources